Zebrafish patient-derived xenograft models (zAvatar) can be used to study cancer biology as well as to predict patient clinical outcomes and response to therapies. Here, in a cohort of 55 patients with colorectal cancer, the authors report that the zAvatar-test can predict response to chemotherapy and clinical outcome with 91% accuracy.
- Bruna Costa
- Marta F. Estrada
- Rita Fior
